152 related articles for article (PubMed ID: 1932515)
21. T cells in cardiac myosin-induced myocarditis.
Neu N; Pummerer C; Rieker T; Berger P
Clin Immunol Immunopathol; 1993 Aug; 68(2):107-10. PubMed ID: 8358856
[TBL] [Abstract][Full Text] [Related]
22. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells.
Pummerer CL; Grässl G; Sailer M; Bachmaier KW; Penninger JM; Neu N
Lab Invest; 1996 May; 74(5):845-52. PubMed ID: 8642780
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice.
Kuan AP; Zuckier L; Liao L; Factor SM; Diamond B
Circ Res; 2000 Feb; 86(3):281-5. PubMed ID: 10679479
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis.
Lauer B; Padberg K; Schultheiss HP; Strauer BE
J Am Coll Cardiol; 1994 Jan; 23(1):146-53. PubMed ID: 8277073
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune mechanisms in myosin-induced myocarditis.
Pummerer C; Grässl G; Neu N
Eur Heart J; 1995 Dec; 16 Suppl O():71-4. PubMed ID: 8682107
[TBL] [Abstract][Full Text] [Related]
26. Cardiac alpha-myosin heavy chains differ in their induction of myocarditis. Identification of pathogenic epitopes.
Liao L; Sindhwani R; Leinwand L; Diamond B; Factor S
J Clin Invest; 1993 Dec; 92(6):2877-82. PubMed ID: 7504694
[TBL] [Abstract][Full Text] [Related]
27. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
Blyszczuk P; Behnke S; Lüscher TF; Eriksson U; Kania G
Biochim Biophys Acta; 2013 Apr; 1833(4):934-44. PubMed ID: 23103516
[TBL] [Abstract][Full Text] [Related]
28. LPS promotes CB3-induced myocarditis in resistant B10.A mice.
Lane JR; Neumann DA; Lafond-Walker A; Herskowitz A; Rose NR
Cell Immunol; 1991 Aug; 136(1):219-33. PubMed ID: 1647882
[TBL] [Abstract][Full Text] [Related]
29. Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response.
Fontes JA; Barin JG; Talor MV; Stickel N; Schaub J; Rose NR; Čiháková D
Immun Inflamm Dis; 2017 Jun; 5(2):163-176. PubMed ID: 28474508
[TBL] [Abstract][Full Text] [Related]
30. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice.
Pummerer CL; Luze K; Grässl G; Bachmaier K; Offner F; Burrell SK; Lenz DM; Zamborelli TJ; Penninger JM; Neu N
J Clin Invest; 1996 May; 97(9):2057-62. PubMed ID: 8621795
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
[TBL] [Abstract][Full Text] [Related]
32. A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8.
Taylor JA; Havari E; McInerney MF; Bronson R; Wucherpfennig KW; Lipes MA
J Immunol; 2004 Feb; 172(4):2651-8. PubMed ID: 14764740
[TBL] [Abstract][Full Text] [Related]
33. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease.
Bachmaier K; Pummerer C; Kozieradzki I; Pfeffer K; Mak TW; Neu N; Penninger JM
Circulation; 1997 Feb; 95(3):655-61. PubMed ID: 9024154
[TBL] [Abstract][Full Text] [Related]
34. T cells with similar T-cell receptor beta-chain complementarity-determining region 3 motifs infiltrate inflammatory lesions of synthetic peptides inducing rat autoimmune myocarditis.
Hanawa H; Inomata T; Okura Y; Hirono S; Ogawa Y; Izumi T; Kodama M; Aizawa Y
Circ Res; 1998 Jul; 83(2):133-40. PubMed ID: 9686752
[TBL] [Abstract][Full Text] [Related]
35. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin.
Fairweather D; Lawson CM; Chapman AJ; Brown CM; Booth TW; Papadimitriou JM; Shellam GR
Immunology; 1998 Jun; 94(2):263-70. PubMed ID: 9741351
[TBL] [Abstract][Full Text] [Related]
36. Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.
Bahk TJ; Daniels MD; Leon JS; Wang K; Engman DM
Int J Cardiol; 2008 Mar; 125(1):85-93. PubMed ID: 17588693
[TBL] [Abstract][Full Text] [Related]
37. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
[TBL] [Abstract][Full Text] [Related]
38. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.
Liao L; Sindhwani R; Rojkind M; Factor S; Leinwand L; Diamond B
J Exp Med; 1995 Mar; 181(3):1123-31. PubMed ID: 7869033
[TBL] [Abstract][Full Text] [Related]
39. The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected].
Penninger JM; Neu N; Timms E; Wallace VA; Koh DR; Kishihara K; Pummerer C; Mak TW
J Exp Med; 1993 Nov; 178(5):1837-42. PubMed ID: 8228830
[TBL] [Abstract][Full Text] [Related]
40. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat.
Li Y; Heuser JS; Kosanke SD; Hemric M; Cunningham MW
J Immunol; 2004 Mar; 172(5):3225-34. PubMed ID: 14978130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
